GlassScriptPhysician profile
David Anthony Distefano
NPI 1083173082
$30,761.30
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $18K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $5,555 · Food and Beverage: $3,706 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $5,554.84 |
| Food and Beverage | $3,706.46 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,382.90 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Trigen Intertan, Na |
| Arthrex, INC. | $10,000.00 | 2024 | |
| Encore Medical, LP | $4,776.42 | 2024-2025 | Djo Surgical |
| Stryker Corporation | $1,678.51 | 2024-2025 | Blueprint Patient Specific Instrumentation, Mako, Alphavent |
| Shoulder Innovations, INC. | $1,432.34 | 2024-2025 | Inset System |
| Medical Device Business Services, INC. | $1,413.29 | 2025 | Inhance, Velys |
| Prodigy Surgical Distribution, INC. | $396.08 | 2025 | |
| Depuy Synthes Sales INC. | $209.08 | 2024-2025 | Tfn-Advance |
| Joint Restoration Foundation, INC. | $170.14 | 2025 | |
| Solventum Corporation | $128.00 | 2024 | V.A.C. Veraflo, Prevena |
| Zimmer Biomet Holdings, INC. | $115.60 | 2025 | Comprehensive Shoulder System |
| Gemini Mountain Medical, LLC | $25.13 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $17.49 | 2025 | |
| Medacta USA, INC. | $16.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Distefano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.